NZ315410A - Substituted seco indolines and their use as prodrugs for adept and gdept - Google Patents

Substituted seco indolines and their use as prodrugs for adept and gdept

Info

Publication number
NZ315410A
NZ315410A NZ315410A NZ31541096A NZ315410A NZ 315410 A NZ315410 A NZ 315410A NZ 315410 A NZ315410 A NZ 315410A NZ 31541096 A NZ31541096 A NZ 31541096A NZ 315410 A NZ315410 A NZ 315410A
Authority
NZ
New Zealand
Prior art keywords
indolines
gdept
adept
prodrugs
seco
Prior art date
Application number
NZ315410A
Other languages
English (en)
Inventor
William Alexander Denny
Moana Tercel
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of NZ315410A publication Critical patent/NZ315410A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NZ315410A 1995-08-18 1996-08-19 Substituted seco indolines and their use as prodrugs for adept and gdept NZ315410A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516943.9A GB9516943D0 (en) 1995-08-18 1995-08-18 Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
PCT/NZ1996/000083 WO1997007097A1 (en) 1995-08-18 1996-08-19 Cyclopropylindoles and their seco precursors, and their use as prodrugs

Publications (1)

Publication Number Publication Date
NZ315410A true NZ315410A (en) 1999-07-29

Family

ID=10779431

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ315410A NZ315410A (en) 1995-08-18 1996-08-19 Substituted seco indolines and their use as prodrugs for adept and gdept

Country Status (8)

Country Link
US (1) US5985909A (https=)
EP (1) EP0850220A1 (https=)
JP (1) JPH11511113A (https=)
AU (1) AU707644B2 (https=)
CA (1) CA2229264A1 (https=)
GB (1) GB9516943D0 (https=)
NZ (1) NZ315410A (https=)
WO (1) WO1997007097A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334344A (en) * 1996-09-12 2000-08-25 Cancer Res Campaign Tech benzo[e]indole and pyrrolo[3,2-e]indole compounds and their use as prodrugs
US6130237A (en) * 1996-09-12 2000-10-10 Cancer Research Campaign Technology Limited Condensed N-aclyindoles as antitumor agents
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
EP0887348A1 (en) * 1997-06-25 1998-12-30 Boehringer Mannheim Italia S.p.A. Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
DE69930328T2 (de) 1998-08-27 2006-12-14 Spirogen Ltd., Ryde Dimere Pyrrolobenzodiazepine
US6909006B1 (en) * 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
EP2357009A1 (en) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
ZA200507752B (en) * 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
CN102746336B (zh) 2005-06-29 2015-08-19 施瑞修德制药公司 氨基磷酸酯烷化剂前体药物
EP1994000B1 (en) * 2006-02-02 2017-08-23 Syntarga B.V. Water-soluble cc-1065 analogs and their conjugates
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2114157B1 (en) * 2006-12-26 2021-05-26 ImmunoGenesis, Inc. Phosphoramidate alkylator prodrug for the treatment of cancer
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US20090118031A1 (en) * 2007-11-01 2009-05-07 Qualizza Gregory K Shaft Structure with Configurable Bending Profile
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
AU2011243294C1 (en) 2010-04-21 2015-12-03 Syntarga B.V. Novel conjugates of CC-1065 analogs and bifunctional linkers
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
EP2970269B1 (en) 2013-03-14 2017-04-19 Novartis AG 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
EP3089963A1 (en) 2013-10-30 2016-11-09 Novartis AG 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
AU2022238571A1 (en) 2021-03-18 2023-09-14 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340243B1 (en) * 1986-12-19 1994-09-28 The Upjohn Company Cc-1065 analogs
GB8705477D0 (en) * 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
AU648313B2 (en) * 1990-04-25 1994-04-21 Pharmacia & Upjohn Company Novel CC-1065 analogs
CA2122036C (en) * 1991-10-23 2002-09-17 Gillian Anlezark Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
NZ240785A (en) * 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments
GB9314960D0 (en) * 1992-07-23 1993-09-01 Zeneca Ltd Chemical compounds
GB9323008D0 (en) * 1993-11-05 1994-01-05 Connors Thomas Improvements relating to cancer therapy

Also Published As

Publication number Publication date
US5985909A (en) 1999-11-16
GB9516943D0 (en) 1995-10-18
AU6710996A (en) 1997-03-12
WO1997007097A1 (en) 1997-02-27
EP0850220A1 (en) 1998-07-01
AU707644B2 (en) 1999-07-15
CA2229264A1 (en) 1997-02-27
JPH11511113A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
NZ315410A (en) Substituted seco indolines and their use as prodrugs for adept and gdept
HU9402983D0 (en) Indol derivatives
ZA942383B (en) New indole derivatives
ZA941483B (en) Indole derivatives
ZA947948B (en) Indole derivatives
AU3087895A (en) Towing apparatus
GB9326332D0 (en) Indole derivatives
GB9319297D0 (en) Indole derivatives
AU8687991A (en) Prodrugs for beta-lactamase and uses thereof
ZA942805B (en) Indole derivatives
AU6764896A (en) Tlp tension adjust system
AU2207195A (en) Modified receptors that continuously signal
AU1549195A (en) Animal box device
HRP960015B1 (en) Substituted indole derivatives
GB9508740D0 (en) Modified polyolefins
GB9603022D0 (en) Proximity warning light
GB9302577D0 (en) Indole derivatives
NO20000740D0 (no) Definering av kvalitet på transmisjon i et transmisjonssystem
GB9310092D0 (en) Indole derivatives
SG38925A1 (en) Substituted indole derivatives
GB9307080D0 (en) Indole derivatives
GB9319299D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives
GB9523097D0 (en) Indole derivatives
HRP920301A2 (en) Black masterbatch for polyethylene

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: AUCKLAND UNISERVICES LIMITED, NZ

Free format text: OLD OWNER(S): CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED

RENW Renewal (renewal fees accepted)